Abstract
Taking a genome-wide association study approach, we identified inherited genetic variations in ACYP2 associated with cisplatin-related ototoxicity (rs1872328: P = 3.9 × 10 -8, hazard ratio = 4.5) in 238 children with newly diagnosed brain tumors, with independent replication in 68 similarly treated children. The ACYP2 risk variant strongly predisposed these patients to precipitous hearing loss and was related to ototoxicity severity. These results point to new biology underlying the ototoxic effects of platinum agents.
Cite
CITATION STYLE
Xu, H., Robinson, G. W., Huang, J., Lim, J. Y. S., Zhang, H., Bass, J. K., … Yang, J. J. (2015). Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss. Nature Genetics, 47(3), 263–266. https://doi.org/10.1038/ng.3217
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
